Informations générales (source: ClinicalTrials.gov)
Planned Mode of Delivery After Caesarean: a Comparative Prospective National Population-based Cohort Study (CICAMODA)
Observational
Assistance Publique Hopitaux De Marseille (Voir sur ClinicalTrials)
août 2022
juillet 2025
29 juin 2024
In women with one previous caesarean, the choice of mode of delivery is determined by a
shared decision-making process between the women and the obstetrician, with the two
options being a trial of labour after caesarean (TOLAC) or an elective repeat caesarean
delivery (ERCD).
To date, the scientific literature has reported of higher perinatal morbidity-mortality
with TOLAC, although with low absolute risks and discordant results about maternal
morbidity-mortality. These studies suffer from limitations, as they include women with
more than one previous caesarean or with high rates of failed TOLAC, which are two risk
factors for uterine rupture, and the definition of planned versus effective mode of
delivery is not precise in most studies.
However, scientific societies recommend that most women with one previous caesarean
should be offered TOLAC because of the low absolute perinatal risk of this option and the
high maternal and perinatal risk associated with an ERCD in the short- and long-term.
Conversely, the investigators hypothesise that TOLAC would be not inferior to ERCD in
women with one previous caesarean in terms of perinatal morbidity-mortality.
Etablissements
Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
CHI DE CRETEIL | Edouard LECARPENTIER | 26/06/2024 08:44:06 | Contacter | ||
HOPITAL NOVO | PONCELET | 04/07/2024 11:04:56 | Contacter | ||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
Assistance Publique Hôpitaux Marseille - 13354 - Marseille - Bouches-du-rhône - France | Claire MORANDO | Contact (sur clinicalTrials) |
Critères
Femme
Inclusion Criteria:
- Pregnant women age of 18 years or older
- Women admitted to the labour ward at gestational age ≥ 34 weeks
- Women with a singleton pregnancy
- Women with one previous caesarean delivery
- Computer savvy-women
- Pregnant women age of 18 years or older
- Women admitted to the labour ward at gestational age ≥ 34 weeks
- Women with a singleton pregnancy
- Women with one previous caesarean delivery
- Computer savvy-women
Exclusion criteria :
- Women who oppose to participation in the study
- Age < 18 years
- Women admitted to the labour ward at gestational age < 34 weeks
- Women with multiple pregnancy
- Women with more than one previous caesarean or more than one uterine scar
- Women who do not understand the French language
- Women under judicial protection